This pooled analysis of data from 2 phase 3 trials of nivolumab therapy in treatment-naive patients with advanced melanoma assesses the safety and efficacy of continuing treatment beyond progression.
http://ift.tt/2slimma
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Abstract The changes of dissolved organic matter (DOM) components during stabilization process play significant effects on its redox prope...
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου